{{Short description|Application to market a new drug}} '''Marketing Authorisation Application''' ('''MAA''') is an application submitted by a drug manufacturer seeking marketing authorisation, that is permission to bring a medicinal product (for example, a new medicine or generic medicine) to the market.
MAA is part of the official procedure before the Medicines and Healthcare products Regulatory Agency in the United Kingdom<ref>{{cite web|url=http://www.mhra.gov.uk/Howweregulate/Medicines/Licensingofmedicines/Marketingauthorisations/index.htm|title=Apply for a licence to market a medicine in the UK - GOV.UK|website=www.mhra.gov.uk}}</ref> and the Committee for Medicinal Products for Human Use of the European Medicines Agency, a specialised agency of the European Commission. A centralised marketing authorisation, issued by the European Commission, allows the holder to market a medicinal product throughout the European Economic Area (EEA), which comprises the EU Member States, Iceland, Norway and Liechtenstein.<ref>{{cite web|url=https://www.ema.europa.eu/en/human-regulatory/marketing-authorisation|title=Marketing Authorisation - European Medicines Agency}}</ref> In the United States, the equivalent process is called New Drug Application.
==References== {{reflist}}
Category:Drug safety